2617 — TransThera Sciences (Nanjing) Balance Sheet
0.000.00%
Last trade - 00:00- HK$17.00bn
- HK$16.44bn
Annual balance sheet for TransThera Sciences (Nanjing), fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Cash | |||
| Cash and Equivalents | |||
| Short Term Investments | |||
| Cash and Short Term Investments | 838 | 573 | 489 |
| Net Total Receivables | 0.602 | 0.456 | 0.455 |
| Total Inventory | |||
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 846 | 585 | 501 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 31.6 | 28.8 | 24 |
| Net Intangible Assets | |||
| Long Term Notes Receivable | |||
| Other Long Term Assets | |||
| Total Assets | 887 | 630 | 546 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 103 | 103 | 130 |
| Capital Lease Obligations | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Liabilities | 104 | 105 | 130 |
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| ESOP Debt Guarantee | |||
| Other Equity | |||
| Total Equity | 783 | 525 | 416 |
| Total Liabilities & Shareholders' Equity | 887 | 630 | 546 |
| Total Common Shares Outstanding |